Dow Jones Industrial Average 13,435.21 (UP) Week ending 01-03-2013
Gilead Sciences Inc.
(Symbol GILD, $75.72, Split 2:1 - $37.86)
Return on Equity 33.91% PEG Ratio 0.76
Gilead Sciences Inc. is projecting 2012 earnings of $3.84 per share and 2014 earnings of $4.42 per share. GILD has had 5 year sales growth of 20.02% and 5 year earnings growth of 22.37%. The company did 8.46 Billion in sales revenues in 2011 so it is a Mid Cap heading on it's way to becoming a Large Cap stock. I had starting writing this article on Saturday and just finishing now, so the stock has run up a little this week along with Celgene (CELG), so you may need to pick a spot to purchase it. The stock also currently has 21 Strong Buy recommendations and 4 Overweight picks in from analyst. The company has had a 3 year Total Return of 70% with most of that happening this year.
So grab your magic wand and prepare to do battle in 2013, which should be a wild ride with all the government hi-jinx going on. I will try to be on time for this weeks blog.
Keep those spells and potions in hand in case you need them to fend off demons.